These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17376548)

  • 21. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
    Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discomfort assessment in peripheral angiography: randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia.
    Palena LM; Sacco ZD; Brigato C; Sultato E; Barra D; Candeo A; Manzi M
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):1019-25. PubMed ID: 24478190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrocardiographic and hemodynamic adverse effects of contrast media in coronary angiography].
    Wagner J; Zwicker B
    Z Kardiol; 1994 Feb; 83(2):146-54. PubMed ID: 8165845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography.
    Beltramello A; Piovan E; Rosta L
    Eur J Radiol; 1994 May; 18 Suppl 1():S67-72. PubMed ID: 8020521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
    Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiography.
    Simonetti G; Guazzaroni M; Carpanese L; Canalis GC; Urigo F
    Eur J Radiol; 1994 May; 18 Suppl 1():S73-6. PubMed ID: 8020522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
    Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW; Dukovic D; Pagani E
    Acad Radiol; 1995 Jan; 2(1):33-7. PubMed ID: 9419521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of hemodynamic and Doppler echocardiographic effects of a new low osmolar nonionic and a standard ionic contrast agent after left ventriculography.
    Werner GS; Schmidt T; Scholz KH; Figulla HR; Kreuzer H
    Cathet Cardiovasc Diagn; 1994 Sep; 33(1):11-9. PubMed ID: 8001095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
    Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
    Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodixanol in multidetector-row computed tomography angiography (MDCTA): diagnostic accuracy for abdominal aorta and abdominal aortic major-branch diseases using four-, eight- and 16-detector-row CT scanners.
    Nonent M; Thouveny F; Simons P; Cappeliez O; Reiser MF; Duddalwar V; Bonomo L; Liessi G
    Acta Radiol; 2007 Feb; 48(1):48-58. PubMed ID: 17325925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-detector row computed tomographic angiography in the evaluation of infrarenal aorta and peripheral arterial occlusive disease: influence of contrast medium concentration.
    Iezzi R; Cotroneo AR; Filippone A; Giancristofaro D; Storto ML
    J Comput Assist Tomogr; 2008; 32(5):690-6. PubMed ID: 18830096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
    Sohn KH; Kim GW; Lee SY; Kim HS; Cho SH; Han JK; Kang HR
    Eur Radiol; 2019 Oct; 29(10):5314-5321. PubMed ID: 30937592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.